Company / Gross Profit per Share
CHINA PHARMA HOLDINGS, INC. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
-$0.04
FY2025
5-year range
-$0.19 / $0.04
FY2021-FY2025
Trend
-52.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 10 years, ranging from $-0.19 in FY2023 to $0.07 in FY2017.
Based on SEC 10-K filings.
-0.04 in FY2025.
Improved from $-0.19 to $-0.04 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share decreased 52.9% year-over-year.
- Peak gross profit per share was recorded in FY2017.
- Lowest gross profit per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.04 | -52.9% |
| FY2024 | -$0.03 | +85.9% |
| FY2023 | -$0.19 | -79.8% |
| FY2022 | -$0.10 | -343.5% |
| FY2021 | $0.04 | +26.0% |
| FY2020 | $0.03 | -24.9% |
| FY2019 | $0.05 | -20.0% |
| FY2018 | $0.06 | -23.3% |
| FY2017 | $0.07 | +119.8% |
| FY2016 | $0.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026